Bristol-Myers Squibb Company (NYSE:BMY) is one of the top stocks sold by hedge funds. On July 28, Bristol Myers, in ...

Bristol-Myers Squibb’s second quarter saw flat overall sales, but the company surpassed Wall Street expectations for both ...

New Jersey officials are eyeing several efforts, including a massive $500 million incentive program meant to entice more products to be "Made in NJ." ...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

Three quality stocks that generate a lot of dividend income you may want to consider are Verizon Communications (NYSE: VZ), ...

August 16, 2025 10:25 am - Industry revenue for Necitumumab is estimated to rise to $1249.4 million by 2035 from $612.2 million of 2024. The revenue ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

Rigel's Q2 results highlight soaring revenue and raised guidance for 2025. See more on RIGL stock's growth potential, ...

Known for producing companies like Karuna Therapeutics, which was sold to Bristol Myers Squibb for $14 billion, and newly ...